To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis

PHASE3CompletedINTERVENTIONAL
Enrollment

198

Participants

Timeline

Start Date

June 3, 2019

Primary Completion Date

September 30, 2025

Study Completion Date

September 30, 2025

Conditions
Colitis, Ulcerative
Interventions
DRUG

Ozanimod

Ozanimod is an orally bioavailable, small molecule compound that activates the sphingosine 1-phosphate 1 receptor (S1P1) and the S1P 5 receptor (S1P5), although it is more selective towards S1P1 over S1P5

OTHER

Placebo

The placebo is a capsule that contains no study medication but looks exactly like the study medication capsule.

Trial Locations (67)

1138519

Local Institution - 138, Bunkyo-ku

3500495

Local Institution - 131, Iruma-gun

060-8543

Local Institution - 104, Sapporo

663-8501

Local Institution - 105, Nishinomiya

700-8558

Local Institution - 156, Okayama

530-0052

Local Institution - 153, Osaka

545-8586

Local Institution - 132, Osaka

270-1168

Local Institution - 139, Abiko

735-8585

Local Institution - 152, Aki-gun

818-8502

Local Institution - 122, Chikushino-shi

538-0027

Local Institution - 150, Fujiidera

910-8526

Local Institution - 114, Fukui

918-8503

Local Institution - 124, Fukui

810-0001

Local Institution - 161, Fukuoka

812-0033

Local Institution - 164, Fukuoka

815-8555

Local Institution - 155, Fukuoka

500-8717

Local Institution - 140, Gifu

040-8611

Local Institution - 151, Hakodate

036-8203

Local Institution - 133, Hirosaki

734-8530

Local Institution - 160, Hiroshima

734-8551

Local Institution - 106, Hiroshima

317-0077

Local Institution - 126, Hitachi, Ibaraki

820-8505

Local Institution - 162, Iizuka

259-1193

Local Institution - 134, Isehara City, Kanagawa

920-0293

Local Institution - 120, Kahoku-gun

769-1695

Local Institution - 135, Kannonji

634-8522

Local Institution - 101, Kashihara

277-0871

Local Institution - 158, Kashiwa

350-8550

Local Institution - 157, Kawagoe

650-0015

Local Institution - 163, Kobe

650-0017

Local Institution - 130, Kobe

923-8560

Local Institution - 121, Komatsu

963-8501

Local Institution - 144, Kōriyama

830-8543

Local Institution - 142, Kurume

839-0809

Local Institution - 165, Kurume

830-0011

Local Institution - 111, Kurume, Fukuoka

602-8566

Local Institution - 141, Kyoto

790-0024

Local Institution - 118, Matsuyama

105-8471

Local Institution - 108, Minatoku

108-8642

Local Institution - 107, Minatoku

181-8611

Local Institution - 109, Mitaka

020-8505

Local Institution - 110, Morioka

940-8653

Local Institution - 125, Nagaoka

466-8560

Local Institution - 167, Nagoya

700-0013

Local Institution - 136, Okayama

989-6183

Local Institution - 127, Osaki-shi

503-8502

Local Institution - 119, Ōgaki

870-0823

Local Institution - 159, Ōita

520-2192

Local Institution - 113, Ōtsu

849-8501

Local Institution - 154, Saga

336-0963

Local Institution - 116, Saitama

591-8025

Local Institution - 145, Sakai

285-8741

Local Institution - 102, Sakura

060-0033

Local Institution - 103, Sapporo

062-8618

Local Institution - 147, Sapporo

980-0021

Local Institution - 146, Sendai

141-8625

Local Institution - 128, Shinagawa-ku, Tokyo

169-0073

Local Institution - 117, Shinjuku

420-8630

Local Institution - 137, Shizuoka

411-8611

Local Institution - 149, Sunto-gun

760-8557

Local Institution - 112, Takamatsu

569-0086

Local Institution - 115, Takatsuki

569-1096

Local Institution - 143, Takatsuki

171-0021

Local Institution - 166, Toshima-ku

939-8511

Local Institution - 129, Toyama

514-8507

Local Institution - 123, Tsu

320-0003

Local Institution - 148, Utsunomiya

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Celgene

INDUSTRY